Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected

Comments
Loading...
Zinger Key Points

Anson Funds agreed to a $2.25 million settlement with the Securities and Exchange Commission (SEC) over a secret relationship with a short seller affecting two cannabis companies. The SEC found that while Anson Funds disclosed its short position strategy to investors, it did not reveal its collaboration with an activist short publisher, which remains undisclosed.

The Scheme

The SEC detailed that Anson Funds would establish a short position before the release of negative reports by the short seller, reported Bloomberg. These reports often led to a decrease in the target companies’ stock prices, allowing Anson Funds to profit from the drop. The events happened in 2018, and the involved cannabis companies included Namaste Technologies Inc. (now Lifeist Wellness Inc.) LFSWD and India Globalization Capital (now IGC Pharma Inc.) IGC.

The scheme involved coordinated efforts where Anson Funds paid the short seller a share of its profits through third-party invoices for non-existent research services, thus masking the true nature of the transactions.

To learn about cannabis finances and the role of the SEC in the space, join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don’t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off.

Legal Repercussions

The SEC accused Anson Funds of failing to inform investors about this arrangement, rendering its statements about its short-selling strategy misleading. The SEC also noted discrepancies in the firm’s record-keeping related to these transactions. Consequently, Anson Funds agreed to pay a civil penalty of $1.25 million, and Anson Advisors Inc. in Toronto agreed to a $1 million penalty.

Anson Funds defended its actions by stating that its involvement benefited investors and the broader market by highlighting overvalued stocks. However, the SEC criticized the fund for omitting crucial details in its communications with prospective investors and for inaccurately recording payments, thus violating the Advisers Act compliance rules.

Gains for Anson Funds

Bloomberg reported that Anson Funds generated over $4 million in gains from this move. The payment to the short seller, made through a third party, amounted to $1.1 million. This investigation is part of a wider effort by U.S. authorities to examine relationships between hedge funds and bearish researchers, which began three years ago and involves more than 50 stocks. Thus, the sentence inaugurates what can be the first of many scrutinies by the SEC and the Department of Justice (DOJ) into illegal short-selling involving hedge funds and research firms.

IGC Logo
IGCIGC Pharma Inc
$0.2795-%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
17.50
Growth
-
Quality
-
Value
29.30
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In:

Cannabis is evolving—don’t get left behind!

Curious about what’s next for the industry and how to stay ahead in today’s competitive market?

Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.

Secure your spot now before prices go up—this is where the biggest deals and connections happen!

Get your tickets today!